126 related articles for article (PubMed ID: 38730328)
1. Haemophagocytic lymphohistiocytosis caused by GATA2 deficiency: a report on three patients.
Wu L; Wang J; Song D; You Y; Wang Z
BMC Infect Dis; 2024 May; 24(1):482. PubMed ID: 38730328
[TBL] [Abstract][Full Text] [Related]
2. Case Report: Missing zinc finger domains: hemophagocytic lymphohistiocytosis in a GATA2 deficiency patient triggered by non-tuberculous mycobacteriosis.
Huang X; Wu B; Wu D; Huang X; Shen M
Front Immunol; 2023; 14():1191757. PubMed ID: 37680631
[TBL] [Abstract][Full Text] [Related]
3. Association of GATA2 Deficiency With Severe Primary Epstein-Barr Virus (EBV) Infection and EBV-associated Cancers.
Cohen JI; Dropulic L; Hsu AP; Zerbe CS; Krogmann T; Dowdell K; Hornung RL; Lovell J; Hardy N; Hickstein D; Cowen EW; Calvo KR; Pittaluga S; Holland SM
Clin Infect Dis; 2016 Jul; 63(1):41-7. PubMed ID: 27169477
[TBL] [Abstract][Full Text] [Related]
4. GATA2 mutation with recurrent haemophagocytic lymphohistiocytosis and panniculitis: a case report.
Sun L; Xu N; Shen M; Wang R; Sun Y; Zhuang J; Zhao Y; Zeng X; Zhang X
Rheumatology (Oxford); 2021 Jul; 60(7):e229-e231. PubMed ID: 33410496
[No Abstract] [Full Text] [Related]
5. Case Report: Hemophagocytic Lymphohistiocytosis and Non-Tuberculous Mycobacteriosis Caused by a Novel
Mika T; Vangala D; Eckhardt M; La Rosée P; Lange C; Lehmberg K; Wohlschläger C; Biskup S; Fuchs I; Mann J; Ehl S; Warnatz K; Schroers R
Front Immunol; 2021; 12():682934. PubMed ID: 34040617
[TBL] [Abstract][Full Text] [Related]
6. GATA2 mutation in long stand Mycobacterium kansasii infection, myelodysplasia and MonoMAC syndrome: a case-report.
Mendes-de-Almeida DP; Andrade FG; Borges G; Dos Santos-Bueno FV; Vieira IF; da Rocha LKMDS; Mendes-da-Cruz DA; Zancopé-Oliveira RM; Calado RT; Pombo-de-Oliveira MS
BMC Med Genet; 2019 Apr; 20(1):64. PubMed ID: 31035956
[TBL] [Abstract][Full Text] [Related]
7. Life-Threatening Primary Varicella Zoster Virus Infection With Hemophagocytic Lymphohistiocytosis-Like Disease in GATA2 Haploinsufficiency Accompanied by Expansion of Double Negative T-Lymphocytes.
Prader S; Felber M; Volkmer B; Trück J; Schwieger-Briel A; Theiler M; Weibel L; Hambleton S; Seipel K; Vavassori S; Pachlopnik Schmid J
Front Immunol; 2018; 9():2766. PubMed ID: 30564229
[TBL] [Abstract][Full Text] [Related]
8. Haemophagocytic lymphohistiocytosis and Epstein-Barr virus: a complex relationship with diverse origins, expression and outcomes.
El-Mallawany NK; Curry CV; Allen CE
Br J Haematol; 2022 Jan; 196(1):31-44. PubMed ID: 34169507
[TBL] [Abstract][Full Text] [Related]
9. Epstein-Barr virus-related hemophagocytic lymphohistiocytosis complicated with coronary artery dilation and acute renal injury in a boy with a novel X-linked inhibitor of apoptosis protein (XIAP) variant: a case report.
Chen RY; Li XZ; Lin Q; Zhu Y; Shen YY; Xu QY; Zhu XM; Bai ZJ; Li Y
BMC Pediatr; 2020 Oct; 20(1):456. PubMed ID: 33008347
[TBL] [Abstract][Full Text] [Related]
10. GATA2 mutation underlies hemophagocytic lymphohistiocytosis in an adult with primary cytomegalovirus infection.
Suzuki T; Takaya S; Kunimatsu J; Kutsuna S; Hayakawa K; Shibata H; Yasumi T; Ohmagari N
J Infect Chemother; 2020 Feb; 26(2):252-256. PubMed ID: 31350183
[TBL] [Abstract][Full Text] [Related]
11. Requirement for etoposide in the initial treatment of Epstein-Barr virus-associated haemophagocytic lymphohistiocytosis.
Song Y; Wang Y; Wang Z
Br J Haematol; 2019 Sep; 186(5):717-723. PubMed ID: 31115044
[TBL] [Abstract][Full Text] [Related]
12. Epstein-Barr virus-associated haemophagocytic lymphohistiocytosis complicated by neurological involvement in a patient with dermatomyositis: A case report and literature review.
Xu T; Xiong L; Tang L
Mod Rheumatol Case Rep; 2023 Jan; 7(1):293-297. PubMed ID: 35861298
[TBL] [Abstract][Full Text] [Related]
13. Killer cell immunoglobulin-like receptor gene polymorphisms predispose susceptibility to Epstein-Barr virus associated hemophagocytic lymphohistiocytosis in Chinese children.
Qiang Q; Zhengde X; Chunyan L; Zhizhuo H; Junmei X; Junhong A; Zheng C; Henter JI; Kunling S
Microbiol Immunol; 2012 Jun; 56(6):378-84. PubMed ID: 22376216
[TBL] [Abstract][Full Text] [Related]
14. T Cell-Epstein-Barr Virus-Associated Hemophagocytic Lymphohistiocytosis (HLH) Occurs in Non-Asians and Is Associated with a T Cell Activation State that Is Comparable to Primary HLH.
Shamriz O; Kumar D; Shim J; Briones M; Quarmyne MO; Chonat S; Lucas L; Edington H; White MH; Mahajan A; Park S; Chandrakasan S
J Clin Immunol; 2021 Oct; 41(7):1582-1596. PubMed ID: 34173902
[TBL] [Abstract][Full Text] [Related]
15. Disseminated nontuberculous mycobacteriosis and fungemia after second delivery in a patient with MonoMAC syndrome/GATA2 mutation: a case report.
Haraguchi M; Harada N; Watanabe J; Yoshikawa H; Shirai Y; Komura M; Koyama M; Ito J; Tsukune Y; Horimoto Y; Hayashi T; Nagaoka T; Uekusa T; Takahashi K
BMC Infect Dis; 2021 May; 21(1):502. PubMed ID: 34051752
[TBL] [Abstract][Full Text] [Related]
16. Sintilimab treatment for chronic active Epstein-Barr virus infection and Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis in children.
Chen R; Lin Q; Zhu Y; Shen Y; Xu Q; Tang H; Cui N; Jiang L; Dai X; Chen W; Li X
Orphanet J Rare Dis; 2023 Sep; 18(1):297. PubMed ID: 37736751
[TBL] [Abstract][Full Text] [Related]
17. Treatment of Epstein Barr virus-induced haemophagocytic lymphohistiocytosis with rituximab-containing chemo-immunotherapeutic regimens.
Chellapandian D; Das R; Zelley K; Wiener SJ; Zhao H; Teachey DT; Nichols KE;
Br J Haematol; 2013 Aug; 162(3):376-82. PubMed ID: 23692048
[TBL] [Abstract][Full Text] [Related]
18. A case of Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis with severe cardiac complications.
Kawamura Y; Miura H; Matsumoto Y; Uchida H; Kudo K; Hata T; Ito Y; Kimura H; Yoshikawa T
BMC Pediatr; 2016 Oct; 16(1):172. PubMed ID: 27793118
[TBL] [Abstract][Full Text] [Related]
19. Single-Cell Transcriptomic Analysis of Epstein-Barr Virus-Associated Hemophagocytic Lymphohistiocytosis.
Suzuki T; Sato Y; Okuno Y; Torii Y; Fukuda Y; Haruta K; Yamaguchi M; Kawamura Y; Hama A; Narita A; Muramatsu H; Yoshikawa T; Takahashi Y; Kimura H; Ito Y; Kawada JI
J Clin Immunol; 2024 Apr; 44(4):103. PubMed ID: 38642164
[TBL] [Abstract][Full Text] [Related]
20. Epstein-Barr virus central nervous system involvement in Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis.
Yin Q; Wang J; Wang Z
Ann Hematol; 2022 Nov; 101(11):2471-2476. PubMed ID: 36071294
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
